vs

Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and Amarin Corp plc (AMRN). Click either name above to swap in a different company.

ATLANTIC AMERICAN CORP is the larger business by last-quarter revenue ($53.8M vs $45.1M, roughly 1.2× Amarin Corp plc). ATLANTIC AMERICAN CORP runs the higher net margin — 1.1% vs -23.3%, a 24.4% gap on every dollar of revenue. On growth, ATLANTIC AMERICAN CORP posted the faster year-over-year revenue change (20.8% vs 7.0%). Over the past eight quarters, ATLANTIC AMERICAN CORP's revenue compounded faster (7.2% CAGR vs -18.3%).

The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

AAME vs AMRN — Head-to-Head

Bigger by revenue
AAME
AAME
1.2× larger
AAME
$53.8M
$45.1M
AMRN
Growing faster (revenue YoY)
AAME
AAME
+13.8% gap
AAME
20.8%
7.0%
AMRN
Higher net margin
AAME
AAME
24.4% more per $
AAME
1.1%
-23.3%
AMRN
Faster 2-yr revenue CAGR
AAME
AAME
Annualised
AAME
7.2%
-18.3%
AMRN

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AAME
AAME
AMRN
AMRN
Revenue
$53.8M
$45.1M
Net Profit
$577.0K
$-10.5M
Gross Margin
Operating Margin
1.4%
35.5%
Net Margin
1.1%
-23.3%
Revenue YoY
20.8%
7.0%
Net Profit YoY
128.9%
33.0%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAME
AAME
AMRN
AMRN
Q1 26
$45.1M
Q4 25
$49.2M
Q3 25
$53.8M
$49.7M
Q2 25
$55.3M
$72.7M
Q1 25
$50.1M
$42.0M
Q4 24
$49.0M
$62.3M
Q3 24
$44.5M
$42.3M
Q2 24
$47.7M
$67.5M
Net Profit
AAME
AAME
AMRN
AMRN
Q1 26
$-10.5M
Q4 25
$-1.2M
Q3 25
$577.0K
$-7.7M
Q2 25
$3.3M
$-14.1M
Q1 25
$802.0K
$-15.7M
Q4 24
$412.0K
$-48.6M
Q3 24
$-2.0M
$-25.1M
Q2 24
$-684.0K
$1.5M
Gross Margin
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AAME
AAME
AMRN
AMRN
Q1 26
35.5%
Q4 25
-12.9%
Q3 25
1.4%
-22.4%
Q2 25
7.6%
-22.0%
Q1 25
2.1%
-39.9%
Q4 24
1.1%
-84.3%
Q3 24
-5.5%
-59.5%
Q2 24
-1.8%
-0.8%
Net Margin
AAME
AAME
AMRN
AMRN
Q1 26
-23.3%
Q4 25
-2.5%
Q3 25
1.1%
-15.6%
Q2 25
6.0%
-19.4%
Q1 25
1.6%
-37.4%
Q4 24
0.8%
-78.0%
Q3 24
-4.5%
-59.4%
Q2 24
-1.4%
2.3%
EPS (diluted)
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
$0.00
Q3 25
$0.02
$-0.02
Q2 25
$0.15
$-0.03
Q1 25
$0.03
$-0.04
Q4 24
$0.01
$-0.12
Q3 24
$-0.10
$-0.06
Q2 24
$-0.04
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAME
AAME
AMRN
AMRN
Cash + ST InvestmentsLiquidity on hand
$34.4M
$307.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$109.5M
Total Assets
$430.9M
$645.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAME
AAME
AMRN
AMRN
Q1 26
$307.8M
Q4 25
$302.6M
Q3 25
$34.4M
$286.6M
Q2 25
$46.4M
$298.7M
Q1 25
$35.9M
$281.8M
Q4 24
$35.6M
$294.2M
Q3 24
$23.0M
$305.7M
Q2 24
$21.2M
$306.7M
Stockholders' Equity
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
$459.3M
Q3 25
$109.5M
$458.9M
Q2 25
$106.2M
$464.9M
Q1 25
$102.4M
$473.7M
Q4 24
$99.6M
$486.2M
Q3 24
$105.8M
$531.4M
Q2 24
$100.7M
$551.9M
Total Assets
AAME
AAME
AMRN
AMRN
Q1 26
$645.8M
Q4 25
$670.8M
Q3 25
$430.9M
$659.8M
Q2 25
$429.3M
$670.1M
Q1 25
$388.4M
$655.7M
Q4 24
$393.4M
$685.3M
Q3 24
$387.0M
$750.6M
Q2 24
$386.0M
$799.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAME
AAME
AMRN
AMRN
Operating Cash FlowLast quarter
$6.6M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
12.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
11.51×
TTM Free Cash FlowTrailing 4 quarters
$19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
$15.3M
Q3 25
$6.6M
$-12.7M
Q2 25
$9.3M
$16.6M
Q1 25
$-722.0K
$-12.5M
Q4 24
$4.8M
$-13.3M
Q3 24
$90.0K
$-2.4M
Q2 24
$416.0K
$-2.7M
Free Cash Flow
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
Q3 25
$6.6M
Q2 25
$9.1M
Q1 25
$-986.0K
Q4 24
$4.6M
Q3 24
$58.0K
Q2 24
$361.0K
FCF Margin
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
Q3 25
12.3%
Q2 25
16.5%
Q1 25
-2.0%
Q4 24
9.3%
Q3 24
0.1%
Q2 24
0.8%
Capex Intensity
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
Q3 25
0.1%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Cash Conversion
AAME
AAME
AMRN
AMRN
Q1 26
Q4 25
Q3 25
11.51×
Q2 25
2.80×
Q1 25
-0.90×
Q4 24
11.65×
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAME
AAME

Bankers Fidelity$30.0M56%
American Southern$23.7M44%

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

Related Comparisons